News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,317 Results
Type
Article (88987)
Company Profile (555)
Press Release (796756)
Multimedia
Podcasts (248)
Webinars (36)
Section
Business (267092)
Career Advice (4166)
Deals (40036)
Drug Delivery (182)
Drug Development (91804)
Employer Resources (208)
FDA (18612)
Job Trends (17500)
News (398943)
Policy (40027)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3066)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (246)
Alzheimer's disease (2050)
Antibody-drug conjugate (ADC) (601)
Approvals (19019)
Artificial intelligence (939)
ASCO (345)
Autoimmune disease (390)
Automation (71)
Bankruptcy (409)
Best Places to Work (12635)
BIO (79)
BIOSECURE Act (23)
Biosimilars (264)
Biotechnology (336)
Bladder cancer (219)
Brain cancer (87)
Breast cancer (870)
Cancer (6885)
Cardiovascular disease (583)
Career advice (3603)
Career pathing (54)
CAR-T (400)
CDC (77)
Celiac Disease (3)
Cell therapy (1118)
Cervical cancer (60)
Clinical research (79500)
Collaboration (2503)
Commercialization (1)
Company closure (8)
Compensation (1616)
Complete response letters (117)
COVID-19 (3047)
CRISPR (130)
C-suite (1388)
Cystic fibrosis (170)
Data (9120)
Decentralized trials (3)
Denatured (95)
Depression (207)
Dermatology (108)
Diabetes (737)
Diagnostics (7675)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (475)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (338)
Earnings (102664)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139114)
Executive appointments (1244)
FDA (22937)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (37)
Funding (2045)
Gene editing (285)
Generative AI (95)
Gene therapy (880)
GLP-1 (1306)
Government (5571)
Grass and pollen (8)
Guidances (427)
Healthcare (21280)
Hematology (198)
HIV (104)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (370)
Immuno-oncology (124)
Indications (229)
Infectious disease (3461)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (341)
Interviews (823)
IPO (18021)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (25)
Labor market (129)
Layoffs (698)
Leadership (55)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (910)
Lymphoma (495)
Machine learning (70)
Management (68)
Manufacturing (1326)
Marketing (7)
MASH (232)
Medical affairs (1)
Medical device (15330)
Medtech (15536)
Mergers & acquisitions (23395)
Metabolic disorders (1895)
mRNA (283)
Multiple sclerosis (215)
NASH (24)
Neurodegenerative disease (549)
Neuropsychiatric disorders (133)
Neuroscience (3895)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5150)
Now hiring (84)
Obesity (897)
Opinion (384)
Ovarian cancer (256)
Pain (298)
Pancreatic cancer (378)
Parkinson's disease (433)
Partnered (43)
Patents (701)
Patient recruitment (849)
Peanut (72)
People (68264)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24558)
Phase 2 (34534)
Phase 3 (25964)
Pipeline (10612)
Policy (408)
Postmarket research (3561)
Preclinical (11015)
Press Release (72)
Prostate cancer (363)
Psychedelics (80)
Radiopharmaceuticals (385)
Rare diseases (1355)
Real estate (7467)
Recruiting (82)
Regulatory (30783)
Reports (78)
Research institute (2780)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (349)
Series B (253)
Service/supplier (15)
Sickle cell disease (135)
Special edition (33)
Spinal muscular atrophy (193)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (152)
Tariffs (104)
The Weekly (150)
Vaccines (1341)
Venture capital (143)
Weight loss (608)
Women's health (149)
Worklife (25)
Date
Today (88)
Last 7 days (493)
Last 30 days (2156)
Last 365 days (33431)
2026 (18943)
2025 (33214)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1299)
Alabama (103)
Alaska (7)
Arizona (417)
Arkansas (16)
Asia (52501)
Australia (9230)
California (14852)
Canada (4173)
China (1685)
Colorado (639)
Connecticut (653)
Delaware (458)
Europe (121069)
Florida (2236)
Georgia (485)
Hawaii (4)
Idaho (70)
Illinois (1302)
India (113)
Indiana (682)
Iowa (25)
Japan (636)
Kansas (145)
Kentucky (58)
Louisiana (64)
Maine (92)
Maryland (1782)
Massachusetts (10855)
Michigan (430)
Minnesota (827)
Mississippi (7)
Missouri (169)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3931)
New Mexico (36)
New York (3921)
North Carolina (1963)
North Dakota (11)
Northern California (7424)
Ohio (465)
Oklahoma (29)
Oregon (46)
Pennsylvania (2906)
Puerto Rico (33)
Rhode Island (53)
South America (1670)
South Carolina (92)
South Dakota (2)
Southern California (5869)
Tennessee (243)
Texas (2412)
United States (53020)
Utah (446)
Vermont (2)
Virginia (370)
Washington D.C. (88)
Washington State (1206)
West Virginia (4)
Wisconsin (161)
Wyoming (2)
886,317 Results for "olon s p a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 18, 2026
·
1 min read
Press Releases
Akari Therapeutics to Present at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026
·
5 min read
Press Releases
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
May 20, 2026
·
1 min read
Press Releases
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026
·
1 min read
Mergers & acquisitions
Lilly’s $25B+ M&A spree captures half of pharma’s 2026 capacity
Over the past decade, Eli Lilly has bought out more biotechs than any of the other top 12 pharmas by revenue—with 10 of those acquisitions arriving just this year.
June 10, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
Reviva to Participate in a Fireside Chat Hosted by A.G.P. on Brilaroxazine’s Potential Across Multiple Neuropsychiatric Indications
April 23, 2026
·
3 min read
Press Releases
Olon Receives 2025 CMO Excellence in Green Chemistry Award
April 17, 2025
·
2 min read
Biotech Bay
Antheia and Olon Continue Partnership for Biomanufacturing Antheia’s Pipeline of KSMs and APIs for Essential MedicinesOlon to support Antheia’s continued scale up and commercialization of early products
Antheia and Olon Group announced an ongoing partnership to leverage Olon’s vast fermentation infrastructure to manufacture Antheia’s early products.
March 13, 2024
·
2 min read
Deals
JPM26: Attendees Wonder, Where’s Our Big M&A Deal?
There hasn’t been a headline-stealing deal at J.P. Morgan yet. Nevertheless, the mood is positive amid green shoots and a flurry of dealmaking to end 2025.
January 13, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
March 16, 2026
·
12 min read
1 of 88,632
Next
